Bariatric surgery: An IDF statement for obese Type 2 diabetes

J. B. Dixon, P. Zimmet, K. G. Albertit, F. Rubino

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type 2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes. It is an effective, safe and cost-effective therapy for obese Type 2 diabetes. Surgery can be considered an appropriate treatment for people with Type 2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co-morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type 2 diabetes and a BMI of 35 kg/m or more.

LanguageEnglish
JournalObesity Research and Clinical Practice
Volume5
Issue number3
DOIs
Publication statusPublished - 1 Jul 2011
Externally publishedYes

Keywords

  • Comorbidity
  • Gastric
  • Guidelines
  • Registry
  • Surgery

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Dixon, J. B. ; Zimmet, P. ; Albertit, K. G. ; Rubino, F. / Bariatric surgery : An IDF statement for obese Type 2 diabetes. In: Obesity Research and Clinical Practice. 2011 ; Vol. 5, No. 3.
@article{73db3ee77b394cf69569b7c0b453a65b,
title = "Bariatric surgery: An IDF statement for obese Type 2 diabetes",
abstract = "The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type 2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes. It is an effective, safe and cost-effective therapy for obese Type 2 diabetes. Surgery can be considered an appropriate treatment for people with Type 2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co-morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type 2 diabetes and a BMI of 35 kg/m or more.",
keywords = "Comorbidity, Gastric, Guidelines, Registry, Surgery",
author = "Dixon, {J. B.} and P. Zimmet and Albertit, {K. G.} and F. Rubino",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.orcp.2011.07.002",
language = "English",
volume = "5",
journal = "Obesity Research and Clinical Practice",
issn = "1871-403X",
publisher = "Elsevier BV",
number = "3",

}

Bariatric surgery : An IDF statement for obese Type 2 diabetes. / Dixon, J. B.; Zimmet, P.; Albertit, K. G.; Rubino, F.

In: Obesity Research and Clinical Practice, Vol. 5, No. 3, 01.07.2011.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bariatric surgery

T2 - Obesity Research and Clinical Practice

AU - Dixon, J. B.

AU - Zimmet, P.

AU - Albertit, K. G.

AU - Rubino, F.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type 2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes. It is an effective, safe and cost-effective therapy for obese Type 2 diabetes. Surgery can be considered an appropriate treatment for people with Type 2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co-morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type 2 diabetes and a BMI of 35 kg/m or more.

AB - The International Diabetes Federation Taskforce on Epidemiology and Prevention of Diabetes convened a consensus working group of diabetologists, endocrinologists, surgeons and public health experts to review the appropriate role of surgery and other gastrointestinal interventions in the treatment and prevention of Type 2 diabetes. The specific goals were: to develop practical recommendations for clinicians on patient selection; to identify barriers to surgical access and suggest interventions for health policy changes that ensure equitable access to surgery when indicated; and to identify priorities for research. Bariatric surgery can significantly improve glycaemic control in severely obese patients with Type 2 diabetes. It is an effective, safe and cost-effective therapy for obese Type 2 diabetes. Surgery can be considered an appropriate treatment for people with Type 2 diabetes and obesity not achieving recommended treatment targets with medical therapies, especially in the presence of other major co-morbidities. The procedures must be performed within accepted guidelines and require appropriate multidisciplinary assessment for the procedure, comprehensive patient education and ongoing care, as well as safe and standardized surgical procedures. National guidelines for bariatric surgery need to be developed for people with Type 2 diabetes and a BMI of 35 kg/m or more.

KW - Comorbidity

KW - Gastric

KW - Guidelines

KW - Registry

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=80051695344&partnerID=8YFLogxK

U2 - 10.1016/j.orcp.2011.07.002

DO - 10.1016/j.orcp.2011.07.002

M3 - Article

VL - 5

JO - Obesity Research and Clinical Practice

JF - Obesity Research and Clinical Practice

SN - 1871-403X

IS - 3

ER -